Muken Ross 4

What Happened
Muken Ross, CEO of SOPHiA GENETICS SA (SOPH), sold 9,838 shares on July 6, 2026. The reported weighted-average price was $5.22 per share for total proceeds of $51,354. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations arising from recent restricted stock unit (RSU) vestings.

Key Details

• Transaction date: 2026-07-06 (reported on Form 4 filed 2026-07-07). Filing appears timely.
• Price: weighted average $5.22; actual sale prices ranged from $4.97 to $5.43 (see footnote).
• Shares sold: 9,838; total proceeds reported $51,354.
• Shares owned after transaction: not specified in the information provided.
• Notable footnotes:
  • F1: Sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan to satisfy tax withholding for RSU vestings on July 2 and July 3, 2026; trades were non‑discretionary.
  • F2: Price is a weighted average; Reporting Person can provide details of prices per share upon written request.

Context
These sales were performed to cover tax withholding on vested RSUs and were executed under a pre-established 10b5-1 trading plan, which typically indicates the trades were routine and not discretionary. Such tax-withholding sales are common and not necessarily a signal of CEO sentiment about the company’s stock.